Sign In
Buy EXEL
$51.60
+3.06 (+6.30%)
At Close: Jun 03, 2026
Stock Market Today (LIVE): Nvidia Stock Up On GTC News, Markets Rally Despite Oil Hitting $101
09:20am, Tuesday, 17'th Mar 2026
Top insights from the latest market news from Tuesday, March 17, from The Motley Fool analysts on Team Rule Breakers and Team Hidden Gems.
Exelixis (EXEL) Down 2.8% Since Last Earnings Report: Can It Rebound?
12:31pm, Thursday, 12'th Mar 2026
Exelixis (EXEL) reported earnings 30 days ago. What's next for the stock?
Here's Why Exelixis (EXEL) is a Strong Growth Stock
10:45am, Thursday, 12'th Mar 2026
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Exelixis, Inc. (EXEL) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
02:12pm, Wednesday, 11'th Mar 2026
Exelixis, Inc. (EXEL) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
Exelixis, Inc. (EXEL) Presents at The Citizens Life Sciences Conference 2026 Transcript
11:52am, Wednesday, 11'th Mar 2026
Exelixis, Inc. (EXEL) Presents at The Citizens Life Sciences Conference 2026 Transcript
CreativeOne Wealth LLC Raises Position in Exelixis, Inc. $EXEL
05:02am, Wednesday, 11'th Mar 2026
CreativeOne Wealth LLC lifted its position in Exelixis, Inc. (NASDAQ: EXEL) by 135.9% during the undefined quarter, according to the company in its most recent Form 13F filing with the SEC. The instit
Barclays PLC Boosts Stock Holdings in Exelixis, Inc. $EXEL
04:21am, Wednesday, 11'th Mar 2026
Barclays PLC increased its holdings in Exelixis, Inc. (NASDAQ: EXEL) by 11.0% in the undefined quarter, according to its most recent filing with the SEC. The institutional investor owned 732,686 share
Exelixis, Inc. (EXEL) Presents at Leerink Global Healthcare Conference 2026 Transcript
12:40pm, Tuesday, 10'th Mar 2026
Exelixis, Inc. (EXEL) Presents at Leerink Global Healthcare Conference 2026 Transcript
Dimensional Fund Advisors LP Grows Holdings in Exelixis, Inc. $EXEL
05:10am, Tuesday, 10'th Mar 2026
Dimensional Fund Advisors LP increased its holdings in Exelixis, Inc. (NASDAQ: EXEL) by 11.2% in the undefined quarter, according to the company in its most recent filing with the Securities and Excha
Victory Capital Management Inc. Acquires 187,034 Shares of Exelixis, Inc. $EXEL
04:25am, Tuesday, 10'th Mar 2026
Victory Capital Management Inc. boosted its stake in shares of Exelixis, Inc. (NASDAQ: EXEL) by 55.0% during the undefined quarter, according to its most recent 13F filing with the SEC. The firm owned
Exelixis, Inc. (NASDAQ:EXEL) Given Average Recommendation of “Hold” by Analysts
04:00am, Friday, 06'th Mar 2026
Exelixis, Inc. (NASDAQ: EXEL - Get Free Report) has been given a consensus rating of "Hold" by the twenty-three brokerages that are presently covering the company, Marketbeat Ratings reports. Two rese
Exelixis, Inc. (EXEL) Presents at TD Cowen 46th Annual Health Care Conference Transcript
01:52am, Wednesday, 04'th Mar 2026
Exelixis, Inc. (EXEL) Presents at TD Cowen 46th Annual Health Care Conference Transcript
Exelixis (NASDAQ:EXEL) Stock Price Down 9.4% After Analyst Downgrade
01:04am, Tuesday, 03'rd Mar 2026
Exelixis, Inc. (NASDAQ: EXEL - Get Free Report)'s stock price dropped 9.4% during mid-day trading on Monday after Royal Bank Of Canada lowered their price target on the stock from $46.00 to $43.00. Ro
Why Exelixis (EXEL) is a Top Value Stock for the Long-Term
10:41am, Monday, 02'nd Mar 2026
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
3 Reasons Exelixis Stock Could Deliver Market‑Beating Returns Over the Next Decade
04:37am, Saturday, 28'th Feb 2026
Exelixis is looking to break out beyond its cabozantinib franchise. The company reported big earnings growth in 2025.
